The UK Government recently published their Life Sciences Vision, setting clear targets for supporting UK R&D. Cancer Research UK’s CEO, Michelle Mitchell, knows that it requires real investment.

Despite staff working flat out, the pandemic has been devastating for NHS cancer services, writes Cancer Research UK’s chief clinician.

The Welsh Government’s decision to publish just a short statement on how it intends to improve patient care over the next 5 years is unacceptable.

We joined 46 other cancer charities to outline what we need from UK Governments and the NHS coming out of the pandemic to move towards world-leading services.

Professor Willie Hamilton specialises in primary care diagnostics at the University of Exeter, with a particular expertise in cancer.

We published our gender and ethnicity pay gap reports today.

Professor Georgios Lyratzopoulos leads the Epidemiology of Cancer Healthcare and Outcomes (ECHO) Group and CanTest at University College London.

We’ve long felt that Cancer Research UK has a role to play in tackling inequalities, writes Michelle Mitchell.

COVID-19 changed so much of our plans, but it didn’t change everything. In this dark year, there were still pockets of light, writes our CEO Michelle Mitchell.

Last week, the UK Government announced what it would spend money on next year. Overall, the results were a mixed bag – but a step in the right direction, writes Michelle Mitchell.